Sandler Carl Forest - 18 Feb 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Carl Forest Sandler
Issuer symbol
RENB
Transactions as of
18 Feb 2022
Net transactions value
-$61,402
Form type
4
Filing time
23 Feb 2022, 16:18:55 UTC
Previous filing
07 Jan 2022
Next filing
24 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Sale $61,348 -6,792 -0.21% $9.03* 3,189,420 18 Feb 2022 Direct F1
transaction RENB Common Stock Sale $54 -6 -0% $9.00* 3,189,414 23 Feb 2022 Direct F1
holding RENB Common Stock 269,344 18 Feb 2022 By grantor retained annuity trusts
holding RENB Common Stock 4,961,363 18 Feb 2022 By Weird Science, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021.
F2 Mr. Sandler is a member and a manager of Weird Science and has shared voting and disposition power of the shares owned by Weird Science, LLC.